First use of nafazatrom, a new antithrombotic drug, in pregnancy.
D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007238:Infarction / Q000517:prevention & control; D010920:Placenta / Q000098:blood supply; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control*; D011720:Pyrazoles / Q000627:therapeutic use*; D047069:Pyrazolones; D013927:Thrombosis / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D011720:Pyrazoles; D047069:Pyrazolones; C018845:nafazatrom